Prostate Specific Membrane Antigen (PSMA)
Showing 76 - 100 of >10,000
Prostate Cancer Trial in Tomsk (Whole body study and SPECT with [99mTc]Tc-BQ0413)
Enrolling by invitation
- Prostate Cancer
- Whole body study and SPECT with [99mTc]Tc-BQ0413
-
Tomsk, Russian FederationTomskNRMC
Oct 26, 2023
Prostate-specific Membrane Antigen, mCRPC or Advanced/Metastatic Solid Tumors Trial in Meldola (68Ga-PSMA)
Recruiting
- Prostate-specific Membrane Antigen
- mCRPC or Advanced/Metastatic Solid Tumors
-
Meldola, FC, ItalyIstituto Scientifico Romagnolo per lo Studio e la Cura dei Tumor
Feb 25, 2021
Prostate Adenocarcinoma, Stage IIB Prostate Cancer AJCC v7, Stage III Prostate Cancer AJCC v7 Trial in Los Angeles (Computed
Completed
- Prostate Adenocarcinoma
- +3 more
- Computed Tomography
- +2 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Jul 1, 2021
Adenoid Cystic Carcinoma Trial in Beijing (68Ga-PSMA, 1.85GBq (50 mCi) of 177Lu-EB-PSMA-617)
Recruiting
- Adenoid Cystic Carcinoma
- 68Ga-PSMA
- 1.85GBq (50 mCi) of 177Lu-EB-PSMA-617
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Mar 18, 2021
Castrate-Resistant Prostate Cancer Trial in Shanghai (LIGHT-PSMA-CART cells)
Suspended
- Castrate-Resistant Prostate Cancer
- LIGHT-PSMA-CART cells
-
Shanghai, Shanghai, ChinaChanghai Hospital
Jan 25, 2023
Relapsed Prostate Cancer Trial in Lund (External radiation therapy)
Completed
- Relapsed Prostate Cancer
- External radiation therapy
-
Lund, SwedenLund University Hospital
May 25, 2020
Castrate-Resistant Prostate Cancer Trial in Hangzhou (PD1-PSMA-CART cells)
Recruiting
- Castrate-Resistant Prostate Cancer
- PD1-PSMA-CART cells
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital, Zhejiang University
Feb 26, 2022
Prostate Cancer Trial in New York (huJ591)
Active, not recruiting
- Prostate Cancer
-
New York, New YorkWeill Cornell Medical College
Apr 20, 2022
Prostate Cancer Trial in Beijing (Al18F-PSMA-617, 68Ga-PSMA-617)
Recruiting
- Prostate Cancer
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
May 2, 2023
Advanced Prostate Cancer, Metastatic Prostate Cancer, Metastatic Prostate Neuroendocrine Carcinoma Trial in Boston
Not yet recruiting
- Advanced Prostate Cancer
- +2 more
- 18F-fluciclovine
- PET/CT
-
Boston, Massachusetts
- +1 more
Sep 25, 2023
dapted Strategy Including Magnetic Resonance Imaging and
Completed
- Prostate Cancer
- Prostate Adenocarcinoma
-
Ankara, TurkeyAnkara University School of Medicine
Sep 6, 2023
Prostate Carcinoma Trial in Los Angeles (procedure, drug, dietary supplement)
Completed
- Prostate Carcinoma
- Biospecimen Collection
- +4 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Nov 30, 2020
Prostate Cancer Trial in Beijing (68Ga-P16-093, 68Ga-PSMA-11)
Recruiting
- Prostate Cancer
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Nov 1, 2022
Prostate Cancer, Localized Prostate Carcinoma Trial (PSMA-1007 Positron Emission Tomography (PET) scan)
Not yet recruiting
- Prostate Cancer
- Localized Prostate Carcinoma
- PSMA-1007 Positron Emission Tomography (PET) scan
- (no location specified)
Aug 14, 2023
Prostate Cancer, Prostate Inflammation, PSA Trial in Albany (Ibuprofen or Naproxen, PSA test)
Recruiting
- Prostate Cancer
- +2 more
- Ibuprofen or Naproxen
- PSA test
-
Albany, New YorkAlbany Medical Center
Nov 29, 2022
Metastatic Castration-resistant Prostate Cancer Trial (TmPSMA-02)
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer
- TmPSMA-02
- (no location specified)
Aug 3, 2022
Prostate Cancer Trial in Nanjing (68Ga-PSMA-33)
Recruiting
- Prostate Cancer
-
Nanjing, Jiangsu, China68Ga-PSMA-33 PET/CT imaging
Sep 19, 2023
Prostate Cancer Trial in London (177Lu-PNT2002, High Dose Radiation)
Recruiting
- Prostate Cancer
- 177Lu-PNT2002
- High Dose Radiation
-
London, Ontario, CanadaLondon Health Sciences Centre
Nov 22, 2022
Prostate Cancer Trial ([18F]-PSMA-1007)
Not yet recruiting
- Prostate Cancer
- [18F]-PSMA-1007
- (no location specified)
Jan 30, 2023
Prostate Cancer Trial in St Leonards, Perth (177Lu-DOTA-TLX591)
Not yet recruiting
- Prostate Cancer
- 177Lu-DOTA-TLX591
-
St Leonards, New South Wales, Australia
- +1 more
Jul 18, 2022
Prostate Cancer Trial in Beijing (68Ga-PSMA-617, 68Ga-P16-093)
Recruiting
- Prostate Cancer
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Aug 4, 2022